They’re getting absolutely demolished. Hard to buy what they’re selling in terms of their explanation of why Q2 sales were down. Abbott and Medtronic didn’t experience the same decline they did. Nevro’s competitive edge relies on them being the “shiny new toy” and unfortunately I think that ship has sailed.
What’s Nevro’s future going to look like when they’re bumped off the stage by the new closed loop systems that will come out soon?
They’re getting absolutely demolished. Hard to buy what they’re selling in terms of their explanation of why Q2 sales were down. Abbott and Medtronic didn’t experience the same decline they did. Nevro’s competitive edge relies on them being the “shiny new toy” and unfortunately I think that ship has sailed.
What’s Nevro’s future going to look like when they’re bumped off the stage by the new closed loop systems that will come out soon?
The issue is they are still like at a $3B market cap even after the drop, haven’t ever made any money, and the total annual stim market is $1B. With 3 other huge companies competing hard in that space.